Affinivax Funding: $359M Raised, Series C (2021)

Affinivax is based in Cambridge. It has raised $359M in total funding. Latest round: Series C.

Affinivax funding overview

Affinivax is based in Cambridge. Affinivax has raised $359M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in January 2021. The round record for Affinivax runs through 2021; nothing later has been disclosed. Investors on record include Bill & Melinda Gates Foundation, Rock Springs Capital, Foresite Capital, CARB-X. 4 distinct backers are named across the disclosed rounds.

Affinivax at a glance

Total raised
$359M
Latest round
Series C
Latest round date
January 2021
Headquarters
Cambridge
Notable investors
Bill & Melinda Gates Foundation, Rock Springs Capital, Foresite Capital, CARB-X

Frequently asked about Affinivax funding

How much has Affinivax raised?
Affinivax has raised $359M in total disclosed funding across the rounds on record.
Who has invested in Affinivax?
Bill & Melinda Gates Foundation, Rock Springs Capital, Foresite Capital, CARB-X are named among the investors backing Affinivax.
What was the latest Affinivax funding round?
The most recent disclosed round is a Series C, announced in January 2021.
Where is Affinivax based?
Affinivax is based in Cambridge.
When did Affinivax last raise?
The last disclosed Affinivax round closed in January 2021 at Series C.

Totals shown for Affinivax aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

Companies related to Affinivax (31)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026